CORDIS
EU research results

CORDIS

English EN

Developing Novel and Optimal Additive Solutions for Red Blood Cells

Project information

Grant agreement ID: 641093

  • Start date

    1 March 2015

  • End date

    31 August 2016

Funded under:

H2020-EU.1.1.

  • Overall budget:

    € 150 000

  • EU contribution

    € 150 000

Hosted by:

HASKOLI ISLANDS

Iceland

Objective

"The research conducted in SYSTEM_US (ERC Advanced Grant #232816) has led
to the discovery of valuable biomarkers for the quality of red blood cells (RBCs)
in standard blood bank storage conditions. Using a combination of systems
biology and metabolomics, this discovery will lead to the development of novel
RBC storage technologies including additive solutions and diagnostics. These
technologies will become valuable assets in the form of intellectual property to
large transfusion medicine companies and will save thousands of lives over the
coming decades. This proposal covers the needs to fully define the market and
NPV of the developing technology, fully define the regulatory and clinical path of
product approval, file for patents to protect the intellectual property, conduct
necessary validation experiments, and continue to develop relations with
industry contacts."

Host institution

HASKOLI ISLANDS

Address

Saemundargotu 2
101 Reykjavik

Iceland

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 150 000

Beneficiaries (1)

HASKOLI ISLANDS

Iceland

EU Contribution

€ 150 000

Project information

Grant agreement ID: 641093

  • Start date

    1 March 2015

  • End date

    31 August 2016

Funded under:

H2020-EU.1.1.

  • Overall budget:

    € 150 000

  • EU contribution

    € 150 000

Hosted by:

HASKOLI ISLANDS

Iceland